Trump executive order to boost U.S. drug manufacturing: Navarro

WASHINGTON (Reuters) – U.S. President Donald Trump on Thursday will sign an executive order aimed at boosting American drug manufacturing and lowering drug prices, White House trade adviser Peter Navarro said as the administration continues to grapple with the novel coronavirus outbreak.

The order, first reported by USA Today, “establishes Buy American rules for government agencies, strips away regulatory barriers to domestic pharmaceutical manufacturing, and catalyzes the Advanced Manufacturing technologies needed to keep drug prices low,” Navarro tweeted.

It will allow the Department of Health and Human Services to use a 1950 law to procure certain “essential” medicines and other equipment from U.S. companies, although it does not list specific products, USA Today reported, citing the White House.

The order also directs the U.S. Food and Drug Administration and the Environmental Protection Agency to give priority status to U.S. drug ingredient manufacturers during their regulatory review process, and addresses counterfeit medicines sold by third-party sellers, according to the report.

So far, more than 157,000 people in the United States have died from COVID-19 – about 1,000 each day – with 4.8 million known COVID-19 cases.

Trump is expected to sign the order later on Thursday, USA Today said. The Republican president is scheduled to travel to Ohio to visit a Whirlpool manufacturing plant and hold a fundraiser for his re-election campaign before traveling to his New Jersey golf resort for the weekend, according to the White House.

Representatives for the White House did not immediately respond to a request for comment.

(Reporting by Susan Heavey; editing by Jonathan Oatis)

Trump rebukes aide Navarro for attacking popular Fauci

By Steve Holland

WASHINGTON (Reuters) – President Donald Trump issued a rare rebuke of his senior adviser Peter Navarro on Tuesday, saying Navarro should not have written a scathing opinion piece about Anthony Fauci, a top government coronavirus expert who is hugely popular.

Navarro, a trade adviser who at times has expanded his reach within the Trump White House, launched an attack on Fauci in an article for USA Today.

“Dr. Anthony Fauci has a good bedside manner with the public, but he has been wrong about everything I have interacted with him on,” Navarro wrote.

The initial lack of a push-back from the White House for the article fed a belief that Navarro’s article was supported at the top levels of the White House.

But departing for a trip to Atlanta, Trump was asked whether Navarro had gone rogue.

“Well he made a statement representing himself. He shouldn’t be doing that. No, I have a very good relationship with Anthony,” Trump said.

A White House official said Trump did not endorse Navarro’s op-ed and that Navarro was told “explicitly in recent days to de-escalate the situation.” The official said that White House chief of staff Mark Meadows is “fully engaged” on the matter and that Meadows thought Navarro’s article was “unacceptable.”

Fauci is a member of the government’s coronavirus task force led by Vice President Mike Pence. The 79-year-old infectious diseases expert aided the search to treat the HIV disease in the 1980’s and is a revered figure for not letting politics intrude on his judgment.

“We’re all on the same team, including Dr. Fauci,” Trump said. “We all want to get rid of this mess.”

Tensions between Trump and Fauci have emerged at times with the president focused on getting Americans back to work and school while Fauci has urged caution to prevent the spread of infection.

Fauci, in an interview with The Atlantic, said the White House’s recent attacks have been a “major mistake on their part.”

“I can’t explain Peter Navarro. He’s in a world by himself,” Fauci said.

He said he had not spoken with Trump “in a while,” but had been working with Pence on the U.S. struggle to gain control of the virus.

(Reporting by Steve Holland; Editing by Howard Goller)